Mirae Asset Global Etfs Holdings Ltd. Cogent Biosciences, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 49,228 shares of COGT stock, worth $511,971. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,228Holding current value
$511,971% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding COGT
# of Institutions
165Shares Held
114MCall Options Held
104KPut Options Held
163K-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct10.5MShares$109 Million0.24% of portfolio
-
Commodore Capital LP New York, NY9.74MShares$101 Million7.36% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.26MShares$96.3 Million6.08% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$75.8 Million0.0% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA6.96MShares$72.4 Million8.79% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $684M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...